Relationship Between Morbimortality and Basal Activated Clotting Time (ACT) in Patients Undergoing Vascular Surgery
Sponsor
FundaciĆ³ Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT04703582
Collaborator
(none)
30
5
Study Details
Study Description
Brief Summary
Check whether patients with higher comorbidity and risk of complication, estimated using the V (p) -POSSUM score, ACS NSQIP and the ASA classification, present higher baseline activated clotting time values.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Study Design
Study Type:
Observational
Anticipated Enrollment
:
30 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Relationship Between Morbimortality and Basal Activated Clotting Time (ACT) in Patients Undergoing Vascular Surgery
Anticipated Study Start Date
:
Jan 1, 2021
Anticipated Primary Completion Date
:
Mar 1, 2021
Anticipated Study Completion Date
:
Jun 1, 2021
Outcome Measures
Primary Outcome Measures
- Change on baseline Activated Clotting Time with comorbidities [1 day - surgery day]
Activted Clotting Time will be measured with Haemocron Machine just before surgery. Comorbidities will be measured with V(p)Possum, AC NSQUIP and ASA scales.
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
- Patients undergoing vascular surgery requiring intraoperative heparinization
Exclusion Criteria:
-
Pregnant women
-
SARS-CoV-2 PCR positive (performed 24-72h prior to surgery)
-
Severe plaquetopenia <50,000
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- FundaciĆ³ Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
FundaciĆ³ Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
ClinicalTrials.gov Identifier:
NCT04703582
Other Study ID Numbers:
- IIBSP-TCA-2020-92
First Posted:
Jan 11, 2021
Last Update Posted:
Jan 11, 2021
Last Verified:
Jan 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms: